Cowen Downgrades Imago Biosciences Inc (IMGO) to Market Perform Following Takeover
Get Alerts IMGO Hot Sheet
Price: $36.01 --0%
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 11
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 11
Join SI Premium – FREE
Cowen analyst Marc Frahm downgraded Imago Biosciences Inc (NASDAQ: IMGO) from Outperform to Market Perform with a price target of $36.00 after the company agreed to be acquired by Merck.
For an analyst ratings summary and ratings history on Imago Biosciences Inc click here. For more ratings news on Imago Biosciences Inc click here.
Shares of Imago Biosciences Inc closed at $17.40 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Monness, Crespi, Hardt Downgrades Palantir Technologies Inc. (PLTR) to Sell on 'egregiously rich valuation... darkest days of this economic downturn are ahead of us'
- Barclays Downgrades Acciona SA (ANA:SM) (ACIXF) to Equalweight
- Cantor Fitzgerald Downgrades Caledonia Mining Corporation (CMCL) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!